Brian F Porter Selected Research

2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)

1/2021	Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
1/2019	Microtubule-Associated Protein 2 Expression in Canine Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian F Porter Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2016
3	Glioma (Gliomas) 10/2020 - 01/2017
1	Colic (Abdominal Cramps) 01/2021
1	Fever (Fevers) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Poisoning 03/2018
1	Necrosis 03/2018
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Neurocytoma 01/2016
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Oligodendroglioma 05/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 04/2011
1	Infections 11/2009
1	Central Nervous System Infections (Central Nervous System Infection) 11/2009

Drug/Important Bio-Agent (IBA)

2	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2021 - 01/2019
1	EnzymesIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Oligodendrocyte Transcription Factor 2IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Cyclic NucleotidesIBA 01/2019
1	phosphine (phosphane)IBA 03/2018
1	alpha2 Subunit Collagen Type IIBA 01/2018
1	CarcinogensIBA 01/2016
1	SynaptophysinIBA 05/2015
1	AntigensIBA 11/2009

Therapy/Procedure

3	Therapeutics 01/2019 - 04/2011